One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
ﻗﯿﻤﺖ : 300$- ﻗﯿﻤﺖ ﻭﯾﮋﻩ : 100$
Improving access to medicines for neurological disorders
doi : 10.1016/S1474-4422(24)00371-5
Volume 23, Issue 10, October 2024
Important considerations for children with non-dystrophic myotonia
Considerations for future trials in cerebral cavernous malformations
Considerations for future trials in cerebral cavernous malformations
Considerations for future trials in cerebral cavernous malformations – Authors' reply
Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
Mexiletine versus lamotrigine in non-dystrophic myotonias: a randomised, double-blind, head-to-head, crossover, non-inferiority, phase 3 trial
Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial
Brain volume change following anti-amyloid ? immunotherapy for Alzheimer's disease: amyloid-removal-related pseudo-atrophy
Differential diagnosis of suspected multiple sclerosis: global health considerations
Differential diagnosis of suspected multiple sclerosis: considerations in people from minority ethnic and racial backgrounds in North America, northern Europe, and Australasia
